Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation

Oncogene
M T Bengoechea-Alonso, J Ericsson

Abstract

Transforming growth factor-β (TGFβ) signaling regulates multiple cellular processes, including extracellular matrix production, cell growth, apoptosis and differentiation. Dysfunction of TGFβ signaling has been implicated in various human disorders ranging from vascular diseases to cancer. TGFβ signaling is negatively regulated by the transcriptional repressor TGFβ-induced factor 1 (TGIF1). The tumor suppressor Fbxw7 is the substrate-recognition factor of a ubiquitin ligase that targets multiple proteins for degradation, including c-Myc, cyclin E, c-Jun and Notch. Here, we describe that TGIF1 is targeted for degradation by Fbxw7 in a phosphorylation-dependent manner. Inactivation of Fbxw7 results in the accumulation of phosphorylated TGIF1 molecules and repression of TGFβ-dependent transcription. Cancer cell lines with inactivating mutations in Fbxw7 show enhanced levels of TGIF1 and attenuated TGFβ-dependent signaling. Importantly, inactivation of Fbxw7 attenuates TGFβ-dependent regulation of cell growth and migration. Taken together, our results suggest that Fbxw7 is a novel regulator of TGFβ signaling.

References

Oct 6, 1998·Annual Review of Biochemistry·J Massagué
Apr 13, 1999·Cell·D WottonJ Massagué
Dec 22, 1999·The Journal of Biological Chemistry·D WottonJ Massagué
May 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·M PessahA Atfi
Jun 18, 2003·Cell·Yigong Shi, Joan Massagué
Jun 26, 2003·Cancer Science·Kohei MiyazonoTakeshi Imamura
Dec 16, 2003·The Journal of Biological Chemistry·Ryosuke TsunematsuKeiichi I Nakayama
Feb 10, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michael T TetzlaffStephen J Elledge
Mar 6, 2004·Nature·Harith RajagopalanChristoph Lengauer
Apr 23, 2004·The EMBO Journal·Masayoshi YadaKeiichi I Nakayama
May 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·Markus WelckerBruce E Clurman
Oct 11, 2005·Annual Review of Cell and Developmental Biology·Xin-Hua Feng, Rik Derynck
Jan 24, 2006·Molecular and Cellular Biology·Laurent BartholinDavid Wotton
Oct 25, 2008·Cell Cycle·Ichiro Onoyama, Keiichi I Nakayama
Jan 8, 2009·The Journal of Biological Chemistry·Maria T Bengoechea-Alonso, Johan Ericsson
Mar 18, 2009·Developmental Cell·Mary Y Wu, Caroline S Hill
Oct 27, 2009·Development·Aristidis Moustakas, Carl-Henrik Heldin

❮ Previous
Next ❯

Citations

Nov 30, 2011·Cancer Metastasis Reviews·Yabin Cheng, Gang Li
Apr 10, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·I A Voutsadakis
Aug 7, 2012·Nature Communications·Azadeh ArabiOlle Sangfelt
Dec 4, 2013·Genes & Development·Markus WelckerBruce E Clurman
Nov 19, 2013·Leukemia & Lymphoma·Stefan NagelRoderick A F MacLeod
Sep 2, 2015·Oncology Reports·Zhenyu ZhouJie Wang
Mar 25, 2015·Experimental and Molecular Pathology·Pingxiang WuLi Liang
Oct 15, 2014·Cancer Cell·Ryan J DavisBruce E Clurman
Dec 16, 2010·The EMBO Journal·Facundo G Pelorosso, Allan Balmain
Sep 21, 2011·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Surinder M Soond, Andrew Chantry
Feb 11, 2012·The Journal of Pathology·Hayley Davis, Ian Tomlinson
Feb 18, 2012·Upsala Journal of Medical Sciences·Miriam De Boeck, Peter ten Dijke
Jul 30, 2011·Biochemical and Biophysical Research Communications·Kemin SongRongya Yang
Aug 30, 2014·PloS One·Anthony SzedlakCarlo Piermarocchi
Aug 4, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jian-Xin JiangHao Zhang
Jan 27, 2017·Open Biology·Alex E PozhitkovPeter A Noble
Aug 30, 2017·PloS One·Sihem ZitouniCatherine Bonne-Andrea
Jul 31, 2018·Nucleic Acids Research·Ewelina GucaMaria J Macias
Nov 6, 2018·Frontiers in Immunology·Ying LongHonglin Zhu
Jan 27, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Li-Juan ChenHao Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis